We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-12.6%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$323M
AUM Growth
+$40.2M
(+14%)
Cap. Flow
+$98.2M
Cap. Flow
% of AUM
30.39%
Top 10 Holdings %
Top 10 Hldgs %
57.75%
Holding
63
New
17
Increased
10
Reduced
12
Closed
6
Top Buys
| 1 |
Globus Medical
GMED
|
+$17M |
| 2 |
Pfizer
PFE
|
+$15.9M |
| 3 |
Teleflex
TFX
|
+$14.6M |
| 4 |
Travere Therapeutics
TVTX
|
+$12.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$12M |
Top Sells
| 1 |
GE HealthCare
GEHC
|
+$26M |
| 2 |
Cigna
CI
|
+$15.5M |
| 3 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$8.28M |
| 4 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$8.15M |
| 5 |
Humana
HUM
|
+$5.81M |
Sector Composition
| 1 | Healthcare | 99.97% |
| 2 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Labcorp
LH
$22.6B
| $33.9M | 10.5% |
168,809
+3,630
| +2% | +$766K |
|
|
2
Globus Medical
GMED
$10.3B
| $25.7M | 7.94% |
516,981
+304,388
| +143% | +$17M |
|
3
GSK
GSK
$103B
| $18.5M | 5.71% |
509,000
+29,468
| +6% | +$1.05M |
|
4
United Therapeutics
UTHR
$22.4B
| $18.4M | 5.71% |
81,606
+1,680
| +2% | +$387K |
|
|
5
Cigna
CI
$80.2B
| $16.7M | 5.16% |
58,226
-54,448
| -48% | -$15.5M |
|
|
6
GE HealthCare
GEHC
$28B
| $16.5M | 5.1% |
242,308
-357,500
| -60% | -$26M |
|
|
BCYC
7
Bicycle Therapeutics
BCYC
$294M
| $16M | 4.96% |
796,933
-171,738
| -18% | -$3.93M |
|
|
8
Pfizer
PFE
$138B
| $14.9M | 4.63% |
+450,700
| New | +$15.9M |
|
9
Organon & Co
OGN
$3.55B
| $13.3M | 4.12% |
767,000
+362,062
| +89% | +$7.55M |
|
|
10
Teleflex
TFX
$5.76B
| $12.7M | 3.92% |
+64,491
| New | +$14.6M |
|
|
11
Regeneron Pharmaceuticals
REGN
$68.8B
| $12.6M | 3.88% |
+15,250
| New | +$12M |
|
12
Medtronic
MDT
$102B
| $8.68M | 2.69% |
+110,780
| New | +$9.27M |
|
13
Embecta
EMBC
$184M
| $8.55M | 2.65% |
+568,294
| New | +$10.7M |
|
14
Healthcare Services Group
HCSG
$1.65B
| $8.45M | 2.62% |
+810,307
| New | +$10.1M |
|
15
Orthofix Medical
OFIX
$443M
| $8.36M | 2.59% |
+650,000
| New | +$11.7M |
|
16
Zimmer Biomet
ZBH
$17.6B
| $8.24M | 2.55% |
+73,400
| New | +$9.32M |
|
|
17
Travere Therapeutics
TVTX
$5.31B
| $7.91M | 2.45% |
+884,770
| New | +$12.5M |
|
18
Viking Therapeutics
VKTX
$4.41B
| $6.59M | 2.04% |
595,002
+67,345
| +13% | +$963K |
|
|
GRCL
19
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $5.99M | 1.86% |
+2,081,216
| New | +$7.61M |
|
20
BridgeBio Pharma
BBIO
$16.5B
| $5.88M | 1.82% |
+222,947
| New | +$6.33M |
|
|
CNTA
21
DELISTED
Centessa Pharmaceuticals
CNTA
| $4.9M | 1.52% |
756,891
-120,302
| -14% | -$823K |
|
22
ARS Pharmaceuticals
SPRY
$756M
| $4.18M | 1.29% |
1,105,911
+563,335
| +104% | +$3.7M |
|
23
Protagonist Therapeutics
PTGX
$8.44B
| $4.14M | 1.28% |
+248,127
| New | +$4.81M |
|
|
KRTX
24
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $4.08M | 1.26% |
+24,129
| New | +$4.54M |
|
|
RVNC
25
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.93M | 1.22% |
342,477
+200,977
| +142% | +$3.86M |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA